In this role, Paul will lead the company’s global commercial strategy, drive business development initiatives, and play a pivotal role in fostering strategic partnerships.
Paul Orange brings with him a wealth of experience in the bioprocessing industry, having held key leadership positions in various companies. His strategic vision, deep industry knowledge, and proven track record make him an excellent addition to the INFORS HT team.
“We are delighted to welcome Paul to INFORS HT as our Chief Commercial Officer. His extensive experience and strategic insights will be instrumental in driving our commercial growth and strengthening our position as a global leader in bioprocess solutions,” said Anja Hawrylenko, CHRO and representative of the shareholders in the board of directors.
Before joining INFORS HT, Paul most recently served as Chief Commercial Officer & Board member at H.E.L Group. Throughout his career, he has demonstrated a strong commitment to innovation, customer satisfaction, and business excellence. Paul’s leadership skills and passion for advancing bioprocessing technologies align seamlessly with INFORS HT’s mission to empower researchers and bioprocess professionals with cutting-edge solutions.
“I am thrilled to be joining INFORS HT, a company known for its commitment to innovation and excellence in the bioprocessing industry. I look forward to contributing to the continued success and growth of INFORS HT, and I am excited about the opportunities that lie ahead,” commented Paul on his appointment.
Paul holds a PhD in Molecular Neuroscience and a BSc. (Hons) in Anatomy & Cell Biology, both from The University of Sheffield. His commitment to continuous learning and staying at the forefront of industry trends reflects INFORS HT’s dedication to providing state-of-the-art solutions to its customers.
For more information about Paul Orange and his professional background, please visit his LinkedIn profile.